Amla

Clinically Informed Overview

Affiliate Disclosure: This page contains affiliate links. If you choose to purchase through these links, Verus PhytoMed™ may earn a commission at no additional cost to you. Products featured are selected based on predefined evaluation criteria, including formulation quality and alignment with clinical research. Affiliate relationships do not influence product selection.

Last reviewed: July 2026

Amla at a Glance

What It Is
Amla, also known as Indian gooseberry, is the fruit of Phyllanthus emblica L. (syn. Emblica officinalis Gaertn.). It contains hydrolyzable tannins, polyphenols, organic acids, flavonoids, and vitamin C. Standardized amla fruit extracts have been investigated primarily for their effects on lipid metabolism, vascular function, glucose regulation, and inflammatory biomarkers.

Main Benefit
Research suggests standardized amla fruit extract may help maintain healthy cholesterol, triglyceride, glucose, and vascular-function markers already within normal ranges.

The most developed area of human research involves cardiometabolic biomarkers, particularly LDL cholesterol, triglycerides, and high-sensitivity C-reactive protein. However, the available trials are generally small and short, and results vary across formulations and study populations.

What to Expect
Most clinical studies have evaluated standardized amla fruit extracts at total daily intakes of approximately 500–1,000 mg for 8–12 weeks. Several studies have reported improvements in lipid and inflammatory biomarkers during this period. These effects are generally identified through laboratory testing rather than through noticeable day-to-day changes.

Mild digestive effects have been reported in some studies, including:

• Dyspepsia

• Abdominal discomfort

• Nausea

• Changes in bowel habits

These effects appear uncommon and have generally been mild. Taking amla with food may improve tolerability for individuals with sensitive digestion.

Medication Caution
Amla may influence blood glucose, blood pressure, and platelet function. Individuals taking glucose-lowering medications, antihypertensive medications, anticoagulants, or antiplatelet medications should consult a qualified healthcare professional before use.

The Verus Standard
Verus PhytoMed™ prioritizes standardized aqueous amla fruit extracts that clearly identify their polyphenol or hydrolyzable-tannin content and provide dosing aligned with human clinical research.

Capros® is generally prioritized because it has the clearest formulation-specific body of repeated human research. Capros® is an aqueous Phyllanthus emblica fruit extract standardized to contain at least 60% low-molecular-weight hydrolyzable tannins, including emblicanin A, emblicanin B, pedunculagin, and punigluconin. It has most commonly been studied at 250–500 mg twice daily.

What You’ll Learn

Amla has a long history of dietary and traditional use and is increasingly being investigated in cardiometabolic research. This overview summarizes:

• What amla is

• How it is believed to work in the body

• What current clinical research suggests

• Which extract forms have the strongest evidence

• Typical dosing used in studies

• Safety considerations and limitations of the evidence

What Is Amla?

Amla is the edible fruit of the Phyllanthus emblica tree, which is native to India and other parts of South and Southeast Asia. It is also known as:

• Indian gooseberry

• Amalaki

• Emblica officinalis

• Phyllanthus emblica

The fruit has been used as both a food and a traditional botanical preparation. Although several parts of the plant have been used traditionally, most modern human research has evaluated the fruit or a concentrated fruit extract.

Amla contains several classes of naturally occurring compounds, including:

• Hydrolyzable tannins

• Emblicanin A and emblicanin B

• Pedunculagin

• Punigluconin

• Gallic acid

• Ellagic acid

• Flavonoids

• Organic acids

• Vitamin C

The concentration of these constituents varies substantially between fresh fruit, dried powder, juice, and proprietary extracts. A standardized tannin extract should not automatically be assumed to provide a clinically meaningful amount of vitamin C unless vitamin C is separately quantified on the label.

How Amla Works

Amla appears to influence several physiological pathways relevant to cardiometabolic health.

Proposed mechanisms include effects on:

• Cholesterol synthesis and metabolism

• Intestinal cholesterol absorption

• Lipoprotein processing

• Endothelial nitric-oxide signaling

• Oxidative-stress pathways

• Inflammatory signaling

• Glucose metabolism

• Platelet responsiveness

Laboratory and animal studies suggest that amla constituents may influence hepatic HMG-CoA reductase activity, cholesterol transport, antioxidant defenses, and endothelial nitric-oxide availability.

These proposed mechanisms help explain why amla has been investigated for lipid, glucose, inflammatory, and vascular-function outcomes. However, many mechanistic findings have not been fully confirmed in humans and should not be interpreted as evidence that amla prevents or treats cardiovascular or metabolic disease.

Absorption and Metabolism

The hydrolyzable tannins found in amla can be broken down within the gastrointestinal tract into smaller phenolic compounds, including gallic-acid- and ellagic-acid-related metabolites. Some constituents may also undergo further transformation by intestinal microorganisms.

Human pharmacokinetic data remain limited, and absorption may differ according to:

• Extraction method

• Tannin composition

• Dose

• Food intake

• Individual gut microbiome characteristics

For this reason, milligram amounts from different amla powders and extracts cannot be assumed to produce equivalent biological exposure.

What the Research Shows

While individual studies vary, the most consistent areas of human research involve lipid markers, inflammatory biomarkers, glucose regulation, and surrogate measures of vascular function.

Metabolic and Lipid Support

Research suggests standardized amla fruit extracts may support: (Refs. 1-5)

• Healthy LDL cholesterol levels

• Healthy total and non-HDL cholesterol levels

• Healthy triglyceride levels

• Normal HDL cholesterol

• Healthy fasting glucose regulation

• Maintenance of favorable lipoprotein ratios

Research Summary: Meta-analyses of small randomized trials suggest that amla may reduce LDL cholesterol by approximately 15–25 mg/dL under study conditions, with possible improvements in triglycerides, fasting glucose, and inflammatory markers. However, findings vary considerably across studies and extract preparations, and the overall certainty of evidence is low because of small sample sizes, short treatment periods, and substantial heterogeneity. Evidence for HDL cholesterol and HbA1c improvement is less consistent.

Vascular and Inflammatory Support

Standardized amla extracts have also been evaluated for support of: (Refs. 6,7)

• Normal endothelial function

• Healthy nitric-oxide availability

• Normal high-sensitivity C-reactive protein levels

• Healthy antioxidant defenses

• Normal vascular responsiveness

Research Summary: In the nine-trial cardiovascular meta-analysis, amla was associated with an average reduction in high-sensitivity C-reactive protein of approximately 1.7 mg/L compared with placebo. Smaller formulation-specific trials have reported improvements in surrogate measures of endothelial function, particularly with 500 mg twice daily.

Other Support

Emerging research has examined amla in relation to: (Refs. 8-12)

• Normal platelet responsiveness

• Healthy blood-flow characteristics

• Blood-pressure regulation

• Digestive comfort

• Hair-growth physiology

Quality and Standardization

High-quality amla supplements should clearly identify:

• The botanical as Phyllanthus emblica or Emblica officinalis

• The fruit as the plant part used

• Whether the preparation is a powder or extract

• The extraction method when available

• The standardized constituent concentration

• The amount of extract per capsule or serving

• Third-party testing or contaminant-control procedures

Capros® is standardized to a minimum of 60% low-molecular-weight hydrolyzable tannins and has been evaluated in several human trials. Another standardized extracts containing 35% polyphenols, 8% triterpenoids, and 10% amla oil has also been shown to produce favorable lipid findings in clinical studies.

Typical Research Dosing

In clinical research settings, Capros®, a standardized aqueous amla fruit extract has most commonly been evaluated at the following dosing ranges:

• 250-500 mg twice daily

• Total daily intake: 500-1,000 mg

• The 1,000 mg daily dose has been used most consistently in studies evaluating lipid, endothelial-function, and inflammatory outcomes.

Other forms studied include:

Standardized polyphenol, triterpenoid, and amla-oil extract

• 500 mg twice daily

• Total daily intake: 1,000 mg

Dried amla fruit powder and other proprietary extracts

• Dosing varies by formulation and standardization

These dosing ranges reflect clinical study protocols. Because the chemical composition of amla products can vary substantially, doses of Capros®, other proprietary extracts, and whole-fruit powder are not directly interchangeable.

Safety and Tolerability

Amla fruit extracts have generally been well tolerated in short-term clinical studies.

Reported side effects have included:

• Dyspepsia

• Mild gastritis

• Abdominal discomfort

• Nausea

• Headache

• Changes in bowel habits

Amla may have additive effects when combined with:

• Glucose-lowering medications

• Antihypertensive medications

• Antiplatelet medications

• Other supplements that influence platelet function or glucose regulation

These effects are most likely when starting higher doses and often improve when taken with meals.

Individuals taking prescription medications should consult a healthcare professional before use.

Safety Considerations

Avoid use during pregnancy or breastfeeding unless specifically recommended by a qualified healthcare professional. Adequate safety data are not available.

Use additional caution in individuals with:

• A history of hypoglycemia

• A bleeding disorder

• Concurrent anticoagulant or antiplatelet therapy

• Multiple antihypertensive medications

• Planned surgery or an invasive procedure

• Advanced liver disease

• Advanced kidney disease

There is no established amla dose adjustment for reduced kidney or liver function because these populations have not been adequately studied.

Because amla may reduce laboratory platelet aggregation, discontinuation before elective surgery may be considered in consultation with the treating clinician. The appropriate interval has not been established in clinical trials.

Safety and efficacy have not been adequately established in children or adolescents.

Evidence Context

Amla has been evaluated in multiple randomized trials and several systematic reviews and meta-analyses.

When reviewing the evidence, several limitations should be considered.

Many studies:

• Include small sample sizes

• Last only 2–12 weeks

• Evaluate laboratory or surrogate biomarkers rather than clinical outcomes

• Include different populations with widely varying baseline risk

• Use chemically distinct amla extracts

• Have some concern or high risk of bias

• Have been supplied or sponsored by extract manufacturers

The current evidence supports a possible role for standardized amla extract in maintaining healthy cardiometabolic biomarkers. It does not establish prevention of cardiovascular events, diabetes, or other chronic diseases, and it does not support substituting amla for evidence-based pharmacologic treatment when medication is clinically indicated.

Summary

Amla has a developing evidence base for cardiometabolic support, with small clinical trials suggesting possible improvements in LDL cholesterol, triglycerides, fasting glucose, inflammation, and vascular function. However, the evidence remains limited by short study durations, small sample sizes, varied formulations, and a lack of cardiovascular-outcome data. Capros® has the clearest formulation-specific research, typically at 500–1,000 mg daily. Amla is best considered a complementary option alongside established lifestyle and medical care.

Supplement Options

The following products are examples that align with the formulation criteria discussed above. Not all products within a tier are identical; classification reflects general alignment with evaluation criteria.

Premium Tier

Life Extension Advanced Lipid Control

Why we selected it:

• Provides 500 mg of Capros® amla fruit extract per capsule with the clearest formulation-specific body of repeated human clinical research

• The labeled intake of one capsule twice daily provides 1,000 mg, aligning with a commonly studied clinical dose

• Single-ingredient formulation despite the broader-sounding product name

• Manufactured by an established supplement company with extensive quality-control and product-transparency practices

• Selected based on clinical alignment, manufacturer reputation, accessibility, and overall formulation quality

Mid-Tier

Verus PhytoMed™ did not identify a clearly differentiated mid-tier amla product that provided a meaningful advantage in formulation quality, clinical alignment, manufacturer reputation, or cost.

Value Tier

Vitacost ROOT2 Capros® Amla

Why we selected it:

• Uses the same clinically studied Capros® amla extract

• Provides 250 mg per capsule

• Two capsules provide the lower studied intake of 500 mg daily

• Four capsules provide the commonly studied intake of 1,000 mg daily

• Offers a substantially lower-cost entry point while preserving alignment with the evidence-supported branded extract

• Selected as a practical value option for individuals comfortable with taking multiple capsules to reach study-aligned dosing
  
  

Continue exploring:

For detailed study summaries and source data, see the full Amla research reference page.
Amla References
Explore Other Botanicals

FDA Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Medical Disclaimer:
The information provided by Verus PhytoMed™ is for educational purposes only and is not intended as medical advice. This overview summarizes current research and does not provide individualized treatment recommendations. Always consult your physician before starting any new supplement.